Report Details

Global Liquid Biopsy Market: By Products and Services (Instruments, Reagents, and Services & Software), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes, and Others), By Sample Type (Blood Samples, Urine Samples, and Other Biofluid Samples), By Application (Breast Cancer, Colorectal Cancer, Gastrointestinal Cancer, Leukemia, Lung Cancer, Prostate Cancer, and Other Cancers), By Analysis Method (Multi - gene - parallel Analysis and Single Gene Analysis (PCR Microarrays)), By End User (Hospitals, Diagnostic Laboratories, and Academic and Research Institutes), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

ID : 7745209
Date : May 2019
Pages : 197 Pages
Industry : Other


Global liquid biopsy market report gives comprehensive outlook on liquid biopsy products and services across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa MEA. The report on liquid biopsy market gives historical, current, and future market sizes US$ Mn on the basis of product & services type, biomarker type, sample type, application, analysis method, end user, and geographic regions. Global liquid biopsy market estimated to be valued US$ 734 Mn in 2018 and poised to grow at CAGR of 21.4% over 2019-2025. Market for liquid biopsy projected to reach US$ 2345 Mn by 2025 owing to growing need for effective and non-invasive cancer diagnostic tools.
1. Research Methodology
1.1. Secondary and Primary research
1.1.1. Secondary Sources
1.1.2. Primary Sources
1.2. Market Revenue Estimation Methodology
1.3. Key Assumptions
1.4. Acronyms
2. Scope of Study
2.1. Market Definition
2.2. Objective of the Research
2.3. Regions covered in the study
3. Executive summary
4. Global Liquid Biopsy Market Dynamics
4.1. Drivers
4.1.1. Economic Drivers
4.1.2. Demand Side Drivers
4.1.3. Supply Side Drivers
4.2. Restraints
4.3. Opportunities/Unmet Needs of the Market
4.4. Trends
5. Unique Features of the Report
5.1. Competition analysis
5.2. Regulatory landscape
5.3. PESTLE analysis
5.4. Porter’s analysis
6. Global Liquid Biopsy Market Analysis, By Products and Services, 2014 - 2018 and Forecast, 2019 - 2025
6.1. Instruments
6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
6.1.2. Year-over-Year Y-o-Y Growth Analysis %
6.2. Reagents
6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
6.2.2. Year-over-Year Y-o-Y Growth Analysis %
6.3. Services and Software
6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
6.3.2. Year-over-Year Y-o-Y Growth Analysis %
7. Global Liquid Biopsy Market Analysis, By Biomarker Type, 2014 - 2018 and Forecast, 2019 - 2025
7.1. Circulating Tumor Cells CTC
7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
7.1.2. Year-over-Year Y-o-Y Growth Analysis %
7.2. Circulating Tumor DNA ctDNA
7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
7.2.2. Year-over-Year Y-o-Y Growth Analysis %
7.3. Exosomes
7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
7.3.2. Year-over-Year Y-o-Y Growth Analysis %
7.4. Others
7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
7.4.2. Year-over-Year Y-o-Y Growth Analysis %
8. Global Liquid Biopsy Market Analysis, By Sample Type, 2014 - 2018 and Forecast, 2019 - 2025
8.1. Blood Samples
8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
8.1.2. Year-over-Year Y-o-Y Growth Analysis %
8.2. Urine Samples
8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
8.2.2. Year-over-Year Y-o-Y Growth Analysis %
8.3. Other Biofluid Samples
8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
8.3.2. Year-over-Year Y-o-Y Growth Analysis %
9. Global Liquid Biopsy Market Analysis, By Application, 2014 - 2018 and Forecast, 2019 - 2025
9.1. Breast Cancer
9.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.1.2. Year-over-Year Y-o-Y Growth Analysis %
9.2. Colorectal Cancer
9.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.2.2. Year-over-Year Y-o-Y Growth Analysis %
9.3. Gastrointestinal Cancer
9.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.3.2. Year-over-Year Y-o-Y Growth Analysis %
9.4. Leukemia
9.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.4.2. Year-over-Year Y-o-Y Growth Analysis %
9.5. Lung Cancer
9.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.5.2. Year-over-Year Y-o-Y Growth Analysis %
9.6. Prostate Cancer
9.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.6.2. Year-over-Year Y-o-Y Growth Analysis %
9.7. Other Cancers
9.7.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
9.7.2. Year-over-Year Y-o-Y Growth Analysis %
10. Global Liquid Biopsy Market Analysis, By Analysis Method, 2014 - 2018 and Forecast, 2019 - 2025
10.1. Multi - gene - parallel Analysis NGS
10.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
10.1.2. Year-over-Year Y-o-Y Growth Analysis %
10.2. Single Gene Analysis PCR Microarrays
10.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
10.2.2. Year-over-Year Y-o-Y Growth Analysis %
11. Global Liquid Biopsy Market Forecast, By End User Analysis, 2014 - 2018 and Forecast, 2019 - 2025
11.1. Hospitals
11.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
11.1.2. Year-over-Year Y-o-Y Growth Analysis %
11.2. Diagnostic Laboratories
11.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
11.2.2. Year-over-Year Y-o-Y Growth Analysis %
11.3. Academic and Research Institutes
11.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025Revenue, USD Mn
11.3.2. Year-over-Year Y-o-Y Growth Analysis %
12. Liquid Biopsy Market Analysis, By Region, 2014 - 2018 and Forecast, 2019 - 2025
12.1. North America Liquid Biopsy Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.1.1. Products and Services Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.1.1. Instruments
12.1.1.2. Reagents
12.1.1.3. Services and Software
12.1.2. Biomarker Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.2.1. Circulating Tumor Cells CTC
12.1.2.2. Circulating Tumor DNA ctDNA
12.1.2.3. Exosomes
12.1.2.4. Others
12.1.3. Sample Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.3.1. Blood Samples
12.1.3.2. Urine Samples
12.1.3.3. Other Biofluid Samples
12.1.4. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.4.1. Breast Cancer
12.1.4.2. Colorectal Cancer
12.1.4.3. Gastrointestinal Cancer
12.1.4.4. Leukemia
12.1.4.5. Lung Cancer
12.1.4.6. Prostate Cancer
12.1.4.7. Other Cancers
12.1.5. Analysis Method Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.5.1. Multi - gene - parallel Analysis NGS
12.1.5.2. Single Gene Analysis PCR Microarrays
12.1.6. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.6.1. Hospitals
12.1.6.2. Diagnostic Laboratories
12.1.6.3. Academic and Research Institutes
12.1.7. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.1.7.1. U.S.
12.1.7.2. Canada
12.2. Europe Liquid Biopsy Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.2.1. Products and Services Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.1.1. Instruments
12.2.1.2. Reagents
12.2.1.3. Services and Software
12.2.2. Biomarker Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.2.1. Circulating Tumor Cells CTC
12.2.2.2. Circulating Tumor DNA ctDNA
12.2.2.3. Exosomes
12.2.2.4. Others
12.2.3. Sample Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.3.1. Blood Samples
12.2.3.2. Urine Samples
12.2.3.3. Other Biofluid Samples
12.2.4. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.4.1. Breast Cancer
12.2.4.2. Colorectal Cancer
12.2.4.3. Gastrointestinal Cancer
12.2.4.4. Leukemia
12.2.4.5. Lung Cancer
12.2.4.6. Prostate Cancer
12.2.4.7. Other Cancers
12.2.5. Analysis Method Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.5.1. Multi - gene - parallel Analysis NGS
12.2.5.2. Single Gene Analysis PCR Microarrays
12.2.6. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.2.6.1. Hospitals
12.2.6.2. Diagnostic Laboratories
12.2.6.3. Academic and Research Institutes
12.2.7. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and
Y-o-Y Growth %
12.2.7.1. U.K
12.2.7.2. Germany
12.2.7.3. France
12.2.7.4. Italy
12.2.7.5. Spain
12.2.7.6. Russia
12.2.7.7. Poland
12.2.7.8. Rest of Europe
12.3. Asia-Pacific Liquid Biopsy Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.3.1. Products and Services Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.1.1. Instruments
12.3.1.2. Reagents
12.3.1.3. Services and Software
12.3.2. Biomarker Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.2.1. Circulating Tumor Cells CTC
12.3.2.2. Circulating Tumor DNA ctDNA
12.3.2.3. Exosomes
12.3.2.4. Others
12.3.3. Sample Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.3.1. Blood Samples
12.3.3.2. Urine Samples
12.3.3.3. Other Biofluid Samples
12.3.4. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.4.1. Breast Cancer
12.3.4.2. Colorectal Cancer
12.3.4.3. Gastrointestinal Cancer
12.3.4.4. Leukemia
12.3.4.5. Lung Cancer
12.3.4.6. Prostate Cancer
12.3.4.7. Other Cancers
12.3.5. Analysis Method Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.5.1. Multi - gene - parallel Analysis NGS
12.3.5.2. Single Gene Analysis PCR Microarrays
12.3.6. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.3.6.1. Hospitals
12.3.6.2. Diagnostic Laboratories
12.3.6.3. Academic and Research Institutes
12.3.7. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and
Y-o-Y Growth %
12.3.7.1. Japan
12.3.7.2. China
12.3.7.3. India
12.3.7.4. ASEAN
12.3.7.5. Australia & New Zealand
12.3.7.6. Rest of Asia-Pacific
12.4. Latin America Liquid Biopsy Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.4.1. Products and Services Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.1.1. Instruments
12.4.1.2. Reagents
12.4.1.3. Services and Software
12.4.2. Biomarker Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.2.1. Circulating Tumor Cells CTC
12.4.2.2. Circulating Tumor DNA ctDNA
12.4.2.3. Exosomes
12.4.2.4. Others
12.4.3. Sample Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.3.1. Blood Samples
12.4.3.2. Urine Samples
12.4.3.3. Other Biofluid Samples
12.4.4. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.4.1. Breast Cancer
12.4.4.2. Colorectal Cancer
12.4.4.3. Gastrointestinal Cancer
12.4.4.4. Leukemia
12.4.4.5. Lung Cancer
12.4.4.6. Prostate Cancer
12.4.4.7. Other Cancers
12.4.5. Analysis Method Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.5.1. Multi - gene - parallel Analysis NGS
12.4.5.2. Single Gene Analysis PCR Microarrays
12.4.6. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.4.6.1. Hospitals
12.4.6.2. Diagnostic Laboratories
12.4.6.3. Academic and Research Institutes
12.4.7. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and
Y-o-Y Growth %
12.4.7.1. Brazil
12.4.7.2. Mexico
12.4.7.3. Argentina
12.4.7.4. Venezuela
12.4.7.5. Rest of Latin America
12.5. Middle East & Africa MEA Liquid Biopsy Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025
12.5.1. Products and Services Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.1.1. Instruments
12.5.1.2. Reagents
12.5.1.3. Services and Software
12.5.2. Biomarker Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.2.1. Circulating Tumor Cells CTC
12.5.2.2. Circulating Tumor DNA ctDNA
12.5.2.3. Exosomes
12.5.2.4. Others
12.5.3. Sample Type Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.3.1. Blood Samples
12.5.3.2. Urine Samples
12.5.3.3. Other Biofluid Samples
12.5.4. Application Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.4.1. Breast Cancer
12.5.4.2. Colorectal Cancer
12.5.4.3. Gastrointestinal Cancer
12.5.4.4. Leukemia
12.5.4.5. Lung Cancer
12.5.4.6. Prostate Cancer
12.5.4.7. Other Cancers
12.5.5. Analysis Method Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.5.1. Multi - gene - parallel Analysis NGS
12.5.5.2. Single Gene Analysis PCR Microarrays
12.5.6. End User Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.6.1. Hospitals
12.5.6.2. Diagnostic Laboratories
12.5.6.3. Academic and Research Institutes
12.5.7. Country Analysis 2014 – 2018 and Forecast 2019 – 2025 by Revenue USD Mn and Y-o-Y Growth %
12.5.7.1. Gulf Cooperation Council GCC Countries
12.5.7.2. Israel
12.5.7.3. South Africa
12.5.7.4. Rest of MEA
13. Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles Introduction, Financial Analysis, Component & Service Offerings, Key Developments, Strategies, and SWOT Analysis
13.2.1. Biocept Inc. U.S
13.2.2. Bio-Rad Laboratories Inc. U.S
13.2.3. Fraunhofer-Gesellschaft Germany
13.2.4. Guardant Health, Inc. U.S
13.2.5. Janssen Diagnostics, LLC U.S
13.2.6. MDxHealth SA U.S
13.2.7. Myriad Genetics U.S
13.2.8. QIAGEN Netherlands
13.2.9. RainDance Technologies, Inc. U.S
13.2.10. Roche Switzerland
13.2.11. Trovagene Inc. U.S


Please fill the following form to know more details about this Report




RELATED PRODUCTS



CHOOSE A FORMAT


  •  Single User Price : $ 4400
  •  Enterprise User License : $ 6600
  •  Corporate User License : $ 8900

Have A Question ?


  DOWNLOAD SAMPLE



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
John Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Ernest Hemingway
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Jacob Watson

CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team